This is a routine insider sale notice tied to a same-day option exercise, likely for tax or diversification purposes. The amount is immaterial relative to AbbVie's market cap. Monitor for the actual Form 4 filing to confirm execution, but no significant market impact is expected.
ABBV drugs
ABBV drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $293.89entry
- T+1 · 6d ago +0.37%α −0.95% · $294.98
- T+4 · todayOpen
- T+5 · in 9h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Jeffrey R. Stewart, an officer of AbbVie, filed a Form 144 notice of intent to sell 40,619 shares of common stock, with an approximate market value of $11.9 million based on the filing date. The shares were acquired through a stock option exercise on the same day, and the sale is planned for execution on or after November 9, 2026.
Key Facts
- Reporting person: Jeffrey R. Stewart, an officer of AbbVie Inc.
- Shares to be sold: 40,619 shares of common stock
- Approximate dollar value: $11,925,848.07
- Shares acquired via stock option exercise on 11/09/2026
- Proposed sale date: 11/09/2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
Sale of 40,619 shares valued at approximately $11.9 million, representing about 0.002% of AbbVie's $510.3B market cap
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed
- Insider sales around option exercises are common and typically not indicative of negative outlook
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010822 |
| Document: 0001950047-26-010822-index.html | 0001950047-26-010822 |
| Document: 0001950047-26-010822.txt | 0001950047-26-010822 |
Track record
22 reports on ABBV
7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $293.89 Now $294.55 +0.22% settles Dec 9
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 Now $294.55 +2.99% settles Dec 2
- Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
- Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 Now $294.55 +4.20% ▲ +4.20% +7.66% vs SPY
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 Now $294.55 +3.20% ▲ +3.37% +4.53% vs SPY
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 Now $294.55 +11.12% ▲ +9.26% +12.16% vs SPY
- Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 Now $294.55 +11.87% ▲ +8.77% +8.06% vs SPY
- Sep 14, 20269w ago Court Ruling Neutral Not scored Entry $261.43 to $272.69 Now $294.55 +12.67% ▲ +4.30% +1.33% vs SPY
- Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 Now $294.55 +13.20% ▲ +1.00% +2.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers